$0
Calithera Biosciences is a biotechnology business based in the US. Calithera Biosciences shares (CALA) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – an increase of 100% over the previous week. Calithera Biosciences employs 8 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Calithera Biosciences stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Calithera Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CALA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Calithera Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Calithera Biosciences stock price (PINK: CALA)
Use our graph to track the performance of CALA stocks over time.Calithera Biosciences shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.12 |
50-day moving average | $0.02 |
200-day moving average | $0.02 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-7.94 |
Calithera Biosciences price performance over time
Historical closes compared with the close of $0.002 from 2024-10-18
1 week (2024-10-15) | 100.00% |
---|---|
1 month (2024-09-19) | -90.00% |
3 months (2024-07-22) | -80.00% |
6 months (2024-04-22) | -92.00% |
1 year (2023-10-20) | -95.00% |
---|---|
2 years (2022-10-18) | N/A |
3 years (2021-10-22) | 1.87 |
5 years (2019-10-22) | 2.72 |
Calithera Biosciences financials
Gross profit TTM | $-42,705,000 |
---|---|
Return on assets TTM | -56.29% |
Return on equity TTM | -114.14% |
Profit margin | 0% |
Book value | $-0.40 |
Market Capitalization | $9,745 |
TTM: trailing 12 months
Calithera Biosciences share dividends
We're not expecting Calithera Biosciences to pay a dividend over the next 12 months.
Have Calithera Biosciences's shares ever split?
Calithera Biosciences's shares were split on a 1:20 basis on 14 June 2022 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Calithera Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Calithera Biosciences shares which in turn could have impacted Calithera Biosciences's share price.
Calithera Biosciences share price volatility
Over the last 12 months, Calithera Biosciences's shares have ranged in value from as little as $0.0001 up to $0.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Calithera Biosciences's is -0.352. This would suggest that Calithera Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Calithera Biosciences has bucked the trend.
Calithera Biosciences overview
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. .
Frequently asked questions
nullWhat percentage of Calithera Biosciences is owned by insiders?
Currently 1.074% of Calithera Biosciences shares are held by insiders. How many people work for Calithera Biosciences?
Latest data suggests 8 work at Calithera Biosciences. When does the fiscal year end for Calithera Biosciences?
Calithera Biosciences's fiscal year ends in December. Where is Calithera Biosciences based?
Calithera Biosciences's address is: 343 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Calithera Biosciences's ISIN number?
Calithera Biosciences's international securities identification number is: US13089P5070 What is Calithera Biosciences's CUSIP number?
Calithera Biosciences's Committee on Uniform Securities Identification Procedures number is: 13089P101
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question